Sir: We appreciate Dr. Rosen’s interesting report of the efficacy of olanzapine in relieving chronic negative symptoms resistant to risperidone in a patient with schizoaffective disorder, bipolar type. His letter emphasizes several points that are in agreement with emerging data regarding the clinical utility of olanzapine.
From the Editors
Are you a healthcare provider?
Add your NPI to personalize your JCP experience.
This PDF is free for all visitors!